283 related articles for article (PubMed ID: 29864907)
1. Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis.
Liu Z; Zhu P; Zhang L; Xiong B; Tao J; Guan W; Li C; Chen C; Gu J; Duanmu J; Zhang W
Biomed Pharmacother; 2018 Jul; 103():1262-1271. PubMed ID: 29864907
[TBL] [Abstract][Full Text] [Related]
2. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine improved carbon tetrachloride-induced liver fibrosis through its inhibition of the activation of hepatic stellate cells: role of autophagy.
He W; Wang B; Yang J; Zhuang Y; Wang L; Huang X; Chen J
Biol Pharm Bull; 2014; 37(9):1505-9. PubMed ID: 25177034
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
6. Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs/TIMPs system in rats.
Zhang J; Yang A; Wu Y; Guan W; Xiong B; Peng X; Wei X; Chen C; Liu Z
Biomed Pharmacother; 2018 Jan; 97():1586-1594. PubMed ID: 29378386
[TBL] [Abstract][Full Text] [Related]
7. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
8. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis.
Zhang Z; Guo M; Zhao S; Shao J; Zheng S
Free Radic Biol Med; 2016 Dec; 101():272-283. PubMed ID: 27989749
[TBL] [Abstract][Full Text] [Related]
9. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
Cheong KO; Shin DS; Bak J; Lee C; Kim KW; Je NK; Chung HY; Yoon S; Moon JO
Arch Pharm Res; 2016 Feb; 39(2):279-291. PubMed ID: 26667466
[TBL] [Abstract][Full Text] [Related]
10. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways.
Zhao HW; Zhang ZF; Chai X; Li GQ; Cui HR; Wang HB; Meng YK; Liu HM; Wang JB; Li RS; Bai ZF; Xiao XH
Int Immunopharmacol; 2016 Jul; 36():249-255. PubMed ID: 27179304
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of Yiqi Huoxue Recipe in regulating autophagy and reversing liver fibrosis].
Wang BY; Zhao W; Niu XM; Du JH; Fu N; Zhao SX; Wang Y; Wang RQ; Zhang YG; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):365-370. PubMed ID: 28763844
[No Abstract] [Full Text] [Related]
12. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
13. [Study on anti- fibrotic mechanism of Fuzheng -Huayu formula to suppress autophagy in mice].
Huang LW; Jiang N; Ping J; Zhang J; Xu LM
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):621-627. PubMed ID: 31594080
[No Abstract] [Full Text] [Related]
14. Anti-inflammatory and hepatoprotective effects of total flavonoid C-glycosides from Abrus mollis extracts.
Chen M; Wang T; Jiang ZZ; Shan C; Wang H; Wu MJ; Zhang S; Zhang Y; Zhang LY
Chin J Nat Med; 2014 Aug; 12(8):590-8. PubMed ID: 25156284
[TBL] [Abstract][Full Text] [Related]
15. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
16. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
Ji DG; Zhang Y; Yao SM; Zhai XJ; Zhang LR; Zhang YZ; Li H
Biomed Pharmacother; 2018 Jun; 102():26-33. PubMed ID: 29549726
[TBL] [Abstract][Full Text] [Related]
17. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.
Tseng TH; Lin WL; Chen ZH; Lee YJ; Shie MS; Lee KF; Shen CH; Kuo HC
J Transl Med; 2016 Sep; 14(1):263. PubMed ID: 27612633
[TBL] [Abstract][Full Text] [Related]
18. Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice.
Zhang L; Zhang H; Gu J; Xu W; Yuan N; Sun J; Li H
Int Immunopharmacol; 2022 Dec; 113(Pt B):109433. PubMed ID: 36371863
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
